Search

Search results

609 results found

Therapeutic drug monitoring for de-escalating anti-tumor necrosis factor therapy in patients with inflammatory bowel disease.

Gade, Ajay, Alessandra Saraga, Alfonso Elosua, Antony Ishan, Tina Deyhim, Nathan David Vanshelboym Rothschild, Adam S Cheifetz, and Konstantinos Papamichael. 2026. “Therapeutic Drug Monitoring for De-Escalating Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease.”. Expert Review of Clinical Pharmacology 19 (2): 167-74.

Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease.

Roblin, X, S Nancey, K Papamichael, F Mechi, J Ouvrier-Buffet, A L Charlois, A S Peaucelle, et al. 2026. “Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease.”. United European Gastroenterology Journal 14 (3): e70207.

Comparison of Intravascular Imaging-, Physiology-, or Angiography-Guided Approaches for Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.

Saito, Tetsuya, Tadao Aikawa, Yuko Kiyohara, Hiroki A Ueyama, Hisato Takagi, Jose Wiley, Eric A Secemsky, et al. 2026. “Comparison of Intravascular Imaging-, Physiology-, or Angiography-Guided Approaches for Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.”. Journal of the American Heart Association, e046367.